Skip to main content
. 2019 Mar 15;24:147–154. doi: 10.12659/AOT.913869

Table 3.

Multivariable Cox proportional hazards analysis for graft survival.

Graft survival Hazard ratio (95% CI) P-value
Duration of brain death period (hours) 0.933 (0.882–0.987) .015
Donor gender (Female/Male) 1.247 (0.870–1.789) .230
Donor age (years) 1.035 (1.012–1.058) .003
Donor body mass index (kg/m2) 0.965 (0.923–1.009) .120
Expanded criteria donor 1.203 (0.699–2.073) .505
Donor history of hypertension 1.164 (0.781–1.733) .456
Donor hypotensive period(s) 0.921 (0.640–1.325) .657
Donor history of diabetes mellitus 5.415 (1.608–18.237) .006
Donor history of cardiac arrest 1.213 (0.802–1.835) .360
Donor use of inotropic medication 1.886 (0.994–3.578) .088
Donor cause of death: stroke 0.611 (0.398–0.937) .024
Donor cause of death: trauma 0.812 (0.481–1.370) .435
Donor lowest creatinine (μmol/L) 1.001 (1.000–1.001) .013
Recipient gender (Female/Male) 1.088 (0.755–1.567) .651
Recipient age (years) 0.973 (0.959–0.987) .000
Recipient body mass index (kg/m2) 1.008 (0.966–1.051) .726
Recipient dialysis duration (years) 0.996 (0.903–1.099) .939
Cold ischemia time (hours) 1.015 (0.987–1.045) .286
Anastomosis time (minutes) 0.994 (0.980–1.007) .336
Number of HLA mismatches 0.927 (0.808–1.064) .283
Delayed graft function 2.279 (1.541–3.369) .000
Acute graft rejection within 1 year 4.122 (2.541–6.686) .000

HLA – human leukocyte antigen.